triptolide has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YW; Kuo, CS; Lin, CK; Lin, GJ; Sytwu, HK; Yang, CY | 1 |
| Das Majumdar, SK; Dash, R; Maji, S; Muduly, DK; Panda, S; Priyadarshini, M; Rath, R; Samal, SK; Shriwas, O | 1 |
2 other study(ies) available for triptolide and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients.
Topics: Adult; Aged; Aged, 80 and over; Animals; B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Epoxy Compounds; Female; Humans; Immune Checkpoint Inhibitors; Interferon-gamma; Janus Kinase 2; Male; Mice, Inbred NOD; Mice, SCID; Middle Aged; Mouth Neoplasms; Phenanthrenes; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT1 Transcription Factor; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Fluorouracil; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Phenanthrenes; Proto-Oncogene Proteins c-akt; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor; Taxoids | 2019 |